AVENUE THERAPEUTICS, INC. (ATXI) Operating income 2016–2025
AVENUE THERAPEUTICS, INC. (ATXI) annual operating income history from SEC filings — each fiscal year as reported.
-$3.1MFY2025 · since FY2016: -$2.4M → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | +72.7% |
| FY2024 | -$11.3M | +22.4% |
| FY2023 | -$14.5M | -80.8% |
| FY2022 | -$8.0M | -115.2% |
| FY2021 | -$3.7M | +28.3% |
| FY2020 | -$5.2M | +80.2% |
| FY2019 | -$26.3M | -20.4% |
| FY2018 | -$21.8M | -91.0% |
| FY2017 | -$11.4M | -380.5% |
| FY2016 | -$2.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATXI financial trends
ATXI RevenueATXI Net incomeATXI Net marginATXI Gross profitATXI Gross marginATXI Operating marginATXI Operating cash flowATXI Free cash flowATXI Capital expendituresATXI Return on equityATXI Stock buybacksATXI Dividends paidATXI Total assetsATXI Total liabilitiesATXI Shareholders’ equityATXI overview →